Markets:

Overview

News

Currencies

International

Treasuries

Monte Rosa Therapeutics, Inc. - Common Stock (NQ:GLUE)

12.91 +0.26 (+2.06%)

Streaming Delayed Price Updated: 9:50 AM EDT, Sep 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Monte Rosa Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

October 27, 2023

From Monte Rosa Therapeutics, Inc.

Via GlobeNewswire

Monte Rosa Therapeutics Announces $25 Million Registered Direct Offering, Priced At- the-Market Under Nasdaq Rules

October 26, 2023

From Monte Rosa Therapeutics, Inc.

Via GlobeNewswire

Crude Oil Moves Lower; Bank of America Profit Beats Expectations ↗

October 17, 2023

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded down 0.09% to 33,954.39 while the NASDAQ fell 0.37% to...

Via Benzinga

Topics Stocks

Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 17, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 17, 2023

Via Benzinga

Dow Surges 100 Points; Goldman Sachs Posts Upbeat Earnings ↗

October 17, 2023

U.S. stocks traded mostly higher midway through trading, with the Dow Jones falling gaining around 100 points on Tuesday. The Dow traded up 0.31% to 34,090.15 while the NASDAQ fell 0.05% to 13,560.52....

Via Benzinga

Topics Stocks

What's Going On Cancer Player Monte Rosa Therapeutics Stock Today? ↗

October 17, 2023

Monte Rosa Therapeutics Inc (NASDAQ: GLUE) entered into a strategic collaboration and licensing agreement with Roche Holdings AG (OTC:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 17, 2023

Via Benzinga

Monte Rosa Therapeutics Announces Strategic Collaboration with Roche to Discover Novel Molecular Glue Degraders Targeting Cancer and Neurological Diseases

October 17, 2023

From Monte Rosa Therapeutics, Inc.

Via GlobeNewswire

Monte Rosa Therapeutics Announces Interim PK/PD and Clinical Data for MRT-2359 in Phase 1/2 Trial for MYC-Driven Solid Tumors

October 17, 2023

From Monte Rosa Therapeutics, Inc.

Via GlobeNewswire

Monte Rosa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update

August 10, 2023

From Monte Rosa Therapeutics, Inc.

Via GlobeNewswire

Monte Rosa Therapeutics Appoints Dr. Anthony M. Manning to Board of Directors

July 26, 2023

From Monte Rosa Therapeutics, Inc.

Via GlobeNewswire

Monte Rosa Therapeutics Advances Second Development Candidate, MRT-6160, a Novel, Highly Selective Molecular Glue Degrader Targeting VAV1 for the Treatment of Autoimmune Diseases

May 23, 2023

From Monte Rosa Therapeutics, Inc.

Via GlobeNewswire

Monte Rosa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update

May 11, 2023

From Monte Rosa Therapeutics, Inc.

Via GlobeNewswire

Monte Rosa Therapeutics Outlines Progress Across Portfolio of Molecular Glue Degraders and Key Anticipated Milestones for 2023

January 09, 2023

From Monte Rosa Therapeutics, Inc.

Via GlobeNewswire

Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 09, 2023

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.

Via Benzinga

Dow Surges 150 Points; Crude Oil Falls Sharply ↗

November 14, 2022

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday.

Via Benzinga

Monte Rosa Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating MRT-2359, a GSPT1-directed Molecular Glue Degrader, for Treatment of MYC-driven Tumors

November 01, 2022

From Monte Rosa Therapeutics, Inc.

Via GlobeNewswire

5 Value Stocks In The Healthcare Sector ↗

October 17, 2022

What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...

Via Benzinga

Albertsons Companies, Domino's Pizza And Other Big Gainers From Thursday ↗

October 14, 2022

U.S. stocks closed higher on Thursday, with the Dow Jones jumping over 800 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022 ↗

October 13, 2022

Upgrades

Via Benzinga

Monte Rosa Shares Rise As FDA Announced Clearance To MYC-Driven Cancer Study ↗

September 06, 2022

The U.S. Food and Drug Administration (FDA) has announced clearance to Monte Rosa Therapeutics’ (NASDAQ: GLUE) investigational new drug application (IND) for its drug candidate MRT-2359 in patients...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2022 ↗

August 15, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022 ↗

April 28, 2022

Via Benzinga

This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday ↗

July 29, 2022

Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,...

Via Benzinga

63 Biggest Movers From Yesterday ↗

June 17, 2022

Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Thursday after the company announced it received notification of euro 782.1 million of funding from the...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 07, 2022

Gainers TherapeuticsMD (NASDAQ:TXMD) stock moved upwards by 38.1% to $0.29 during Monday's regular session. As of 12:30 EST, TherapeuticsMD's stock is trading at a...

Via Benzinga

53 Biggest Movers From Yesterday ↗

March 30, 2022

Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2022 ↗

February 10, 2022

Upgrades According to Gordon Haskett, the prior rating for Williams-Sonoma Inc (NYSE:WSM) was changed from Hold to Accumulate. Williams-Sonoma earned $3.32 in the third quarter,...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 25, 2022

On Tuesday, 88 companies set new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Credit Suisse Group (NYSE:CS) was the largest, in terms of market cap...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.